| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 07/08/2004 | DE10261874A1 Nichtsteroidale Entzündungshemmer Nonsteroidal anti-inflammatory drugs |
| 07/07/2004 | EP1435384A2 Red light emitting compounds for organic electroluminescent devices and organic electroluminescent devices using them |
| 07/07/2004 | EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 07/07/2004 | EP1434769A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 07/07/2004 | EP0981520B1 Efficient enantioselective addition reaction using an organozinc reagent |
| 07/07/2004 | CN1511145A Oxazin (thi)one compounds used as fungicides |
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/06/2004 | US6759402 Cyclic felbamate derived compounds |
| 07/01/2004 | US20040127658 Productivity catalysts and microstructure control |
| 07/01/2004 | US20040123948 Adjust adhesion at interface of microelectronics packages; shrinkage inhibition |
| 06/30/2004 | EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 06/24/2004 | WO2004052871A1 Benzomorpholine derivatives |
| 06/24/2004 | WO2004052372A1 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction |
| 06/24/2004 | WO2004052360A1 Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof |
| 06/24/2004 | WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 06/24/2004 | US20040122224 copolycarbons used to form synthetic rubbers having low hysteresis and good compatibility with fillers, such as carbon black and silica; tires, hoses and belts |
| 06/24/2004 | US20040122194 Functionalized monomers for synthesis of rubbery polymers |
| 06/24/2004 | US20040122057 Novel mandelic acid derivatives |
| 06/24/2004 | US20040122006 such as 7-[(2-aminophenyl)sulfanyl]-2H-1,4-benzoxazin-3(4H)-one; oxidation/reduction; deblocking/deprotectiing; cardiovascular disorders |
| 06/24/2004 | US20040121490 Metal chelate containing compositions for use in chemiluminescent assays |
| 06/24/2004 | US20040121316 Method and compositions for identifying anti-HIV therapeutic compounds |
| 06/24/2004 | CA2508623A1 Benzomorpholine derivatives |
| 06/23/2004 | EP1430038A1 Ultraviolet light absorbers |
| 06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
| 06/23/2004 | EP1036075B1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties |
| 06/22/2004 | US6753429 1,4-disubstituted benzenes as insecticides |
| 06/17/2004 | WO2004050623A1 Methods for preparing phenylalkyne derivatives |
| 06/17/2004 | WO2004018414A3 Antibacterial agents |
| 06/17/2004 | WO2003106440A3 Process for the synthesis of mosapride |
| 06/17/2004 | US20040116456 Remedies for psychoneurosis |
| 06/17/2004 | CA2507875A1 Methods for preparing phenylalkyne derivatives |
| 06/16/2004 | CN1505607A Peptide-deformylase inhibitors |
| 06/16/2004 | CN1153759C Novel delta-amino-gamma-hydroxy-omega-aryl-alkane amide compounds |
| 06/10/2004 | WO2004048335A2 Mandelic acid derivatives |
| 06/10/2004 | WO2004016578A3 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 06/10/2004 | CA2505542A1 Mandelic acid derivatives |
| 06/09/2004 | EP1426048A2 Treating hypertriglyceridemia with RXR agonists in combination with a PPARgamma agonist |
| 06/09/2004 | CN1502612A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/08/2004 | US6747031 N-heterocyclic derivatives as NOS inhibitors |
| 06/08/2004 | CA2079692C Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
| 06/03/2004 | WO2004046138A1 Carboxamides |
| 06/03/2004 | WO2004046124A1 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders |
| 06/03/2004 | WO2004046119A1 Substituted aralkyl derivatives |
| 06/03/2004 | WO2004045618A2 Novel medicaments for the treatment of chronic obstructive pulmonary diseases |
| 06/03/2004 | WO2003084937A3 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases |
| 06/03/2004 | US20040106825 e.g., disodium N-(5-chlorosalicyloyl)-8-amN-(10-[2-hydroxybenzoyl]amino)decanoate and disodium N-(10-[2-hydroxybenzoyl]amino)decanoate |
| 06/03/2004 | US20040106626 amidine containing compounds which inhibit serine proteases |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | DE10254336A1 Carbonsäureamide Carboxamides |
| 06/03/2004 | CA2506112A1 Substituted aralkyl derivatives |
| 06/02/2004 | EP1423356A2 Novel aminobenzoephenones |
| 06/02/2004 | CN1152016C 2-(3,5-bi-trifluoromethyl-phenyl)-N methyl-N-(6-morpholine-4-yl-4-o-tolyl-pyridine-3-yl)-isobutyramide |
| 06/02/2004 | CN1152014C N-aryl anthranilic acid derivatives and uses thereof |
| 06/01/2004 | US6743852 Benzoxazines, thermosetting resins comprised thereof, and methods for use thereof |
| 06/01/2004 | US6743790 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
| 06/01/2004 | US6743373 Reagent based on enantiopure amino acid in which amino group carries activating group to form active precursor of isocyanate group and carboxyl group is substituted; separation of enantiomers having free functional group |
| 05/27/2004 | US20040102440 Method of promoting smoking cessation |
| 05/27/2004 | US20040101523 Blocking biosynthesis of neurotransmitters; enzyme inhibitors; cardiovascular disorders |
| 05/27/2004 | DE10253282A1 Treatment of chronic obstructive pulmonary disease, using new or known N-substituted 2-amino-1-(benz-(1,4)-oxazin-3-on-8-yl)-ethanol derivative beta-mimetic agents, suitable for once-daily administration |
| 05/26/2004 | EP1421070A1 New piperidinyl derivates as modulators of chemokine receptor activity |
| 05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
| 05/21/2004 | WO2004041792A1 Substituted benzoxazinones and uses thereof |
| 05/21/2004 | WO2003084935A3 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases |
| 05/21/2004 | CA2505334A1 Substituted benzoxazinones and uses thereof |
| 05/20/2004 | US20040097594 Sulfonamide inhibitors of aspartyl protease |
| 05/20/2004 | US20040097589 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 05/20/2004 | US20040097550 For therapy of thrombosis, myocardial infarction, arteriosclerosis, inflammation, apoplexia, angina pectoris, restenosis after angioplasty, claudicatio intermittens, tumours, tumour diseases and/or tumour metastases |
| 05/19/2004 | EP1204416A4 Carnitine analogues as topical, microbicidal spermicides |
| 05/19/2004 | EP0975682B1 Group 8-10 transition metal olefin polymerization catalysts |
| 05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
| 05/19/2004 | CN1498206A Biurethane derivatives |
| 05/13/2004 | US20040092738 Hydrolysis of 3,7-dialkanoyloxyphenoxazine derivative; measuring fluorescence |
| 05/13/2004 | US20040092519 New treatment for hot flashes |
| 05/13/2004 | US20040092517 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 05/13/2004 | US20040092512 Central nervous system disorders; Parkinson's disease; Huntington's diseases; antidepressants; anxiolytic agents |
| 05/12/2004 | EP1418430A2 A homogeneous assay for determining analyte |
| 05/12/2004 | EP1417196A1 Dna-pk inhibitors |
| 05/12/2004 | EP1417167A1 Novel compounds for use as antidepressants, aphrodisiacs and adjunctive therapies in humans |
| 05/12/2004 | EP1140835B1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 05/12/2004 | EP1114037B1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 05/12/2004 | CN1496409A Process for preparation of optically active propoxyaniline derivatives |
| 05/12/2004 | CN1496356A Method of producing N-substituted 2,6-dialdyl morpholines |
| 05/11/2004 | US6734154 Contacting the substrate with a mono-, di-, or trialkoxy-substituted perfluoroalkane, perfluorocycloalkane, or perfluorocycloalkyl(ene)- containing perfluoroalkane |
| 05/06/2004 | WO2004011423A3 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | WO2002089800A3 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 05/06/2004 | US20040087585 Peptide deformylase inhibitors |
| 05/06/2004 | US20040087582 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
| 05/06/2004 | US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists |
| 05/06/2004 | US20040087453 Photo-labile pro-fragrance conjugates |
| 05/06/2004 | EP1414806A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
| 05/05/2004 | CN1494539A Antagonists of MCP-1 function and methods of use thereof |
| 05/04/2004 | US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants |
| 04/29/2004 | WO2004035556A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 04/29/2004 | WO2004014389A8 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 04/29/2004 | WO2004000230A3 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders |
| 04/29/2004 | WO2003093242A3 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 04/29/2004 | US20040082780 Vanilloid receptor ligands and their use in treatments |
| 04/29/2004 | US20040082585 Anticoagulants; controlling thrombosis; cardiovascular disorders |